Trial

NCT04614246

Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Bayer
Collaborators
Condition
Endometriosis
Intervention
BAY1817080
Why stopped
Study terminated by Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-01